4//SEC Filing
Derakhshan Behrad 4
Accession 0001562180-24-006943
CIK 0001710072other
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 8:24 PM ET
Size
9.2 KB
Accession
0001562180-24-006943
Insider Transaction Report
Form 4
Derakhshan Behrad
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2024-09-20$1.93/sh+42,068$81,191→ 57,189 total - Sale
Common Stock
2024-09-20$29.03/sh−42,068$1,221,133→ 15,121 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-09-20−42,068→ 102,949 totalExercise: $1.93Exp: 2030-12-15→ Common Stock (4,763 underlying)
Footnotes (3)
- [F1]Includes 1,699 shares purchased on May 15, 2024 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan.
- [F2]The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.28, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]1/48th of the shares subject to the option vest each month beginning on January 3, 2021, subject to the Reporting Person continuing as a service provider through each vest date.
Documents
Issuer
Edgewise Therapeutics, Inc.
CIK 0001710072
Entity typeother
Related Parties
1- filerCIK 0001853109
Filing Metadata
- Form type
- 4
- Filed
- Sep 23, 8:00 PM ET
- Accepted
- Sep 24, 8:24 PM ET
- Size
- 9.2 KB